Sunday, June 19, 2011

Q: CMV Retinitis can be treated by ganciclovir or foscarnet,   

A) orally,
B) intravenously, 
C) intravitreal injection
D) intravitreal implant
E) All of the above.

Answer: E (all of the above)

Beside regular route of administration it is interesting to note that the Vitrasert ganciclovir implant is a sustained-release intravitreal implant that is used for the treatment of cytomegalovirus (CMV) retinitis. Each implant is designed to release drug over a 5 to 8 month period.